Science Explorer Interactive view Map
Company · New Haven · United States

Achillion Pharmaceuticals (United States)

achillion.comROR OpenAlex
Research works
77
▼ 55% vs 2013–17
Citations
1.5k
18.9 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
34%
world 28%

Not ranked overall: Achillion Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Achillion Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Immune Response, Antiviral Therapy, Liver Disease, Epidemiology, Treatment, Hepatitis C Virus, Ribavirin and Hepatocellular Carcinoma.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immune Response13▲ 28×8 topics
  2. Epidemiology12▲ 4.0×16 topics
  3. Antiviral Therapy11▲ 94×3 topics
  4. Liver Disease11▲ 100×2 topics
  5. Treatment9▲ 8.8×5 topics
  6. Hepatitis C Virus7▲ 168×1 topic
  7. Ribavirin7▲ 168×1 topic
  8. Hepatocellular Carcinoma6▲ 36×2 topics
  9. Chemotherapy6▲ 11×6 topics
  10. Antibiotic Resistance6▲ 18×5 topics
  11. Antiretroviral Therapy6▲ 31×3 topics
  12. Anticancer Drugs5▲ 157×2 topics
  13. DNA5▲ 202×1 topic
  14. Topoisomerases5▲ 202×1 topic
  15. Medicinal Chemistry5▲ 16×5 topics
  16. Anticancer Agents4▲ 23×4 topics
  17. ESKAPE Pathogens4▲ 96×1 topic
  18. Global Burden4▲ 9.5×3 topics
  19. Multidrug-Resistant Bacteria4▲ 96×1 topic
  20. Chronic Hepatitis B4▲ 96×1 topic
  21. Hepatitis B Virus4▲ 96×1 topic
  22. Heterocyclic Compounds4▲ 30×2 topics
  23. Drug Resistance4▲ 14×3 topics
  24. Synthesis3▲ 7.6×4 topics
  25. Inflammatory Diseases3▲ 37×2 topics
  26. HIV Infection3▲ 31×1 topic
  27. Hepatotoxicity3▲ 53×2 topics
  28. Integrase Inhibitors3▲ 93×1 topic
  29. Vaccine3▲ 9.8×6 topics
  30. Genetics3▲ 5.0×2 topics
  31. Complement3▲ 170×1 topic
  32. Immune3▲ 170×1 topic
  33. Antimicrobial Resistance3▲ 13×2 topics
  34. Clinical Management3▲ 17×3 topics
  35. HIV2▲ 27×2 topics
  36. NAFLD2▲ 26×1 topic
  37. NASH2▲ 26×1 topic
  38. Tubulin Inhibitors2▲ 52×1 topic
  39. Vascular Targeting Agents2▲ 52×1 topic
  40. Pancreatic Cancer2▲ 22×2 topics

Which research topics does Achillion Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Atomic and Subatomic Physics Research, Cardiac Arrest and Resuscitation and Cardiovascular Syncope and Autonomic Disorders.

  1. 1 Atomic and Subatomic Physics Research Atomic and Molecular Physics, and Optics 0 works
  2. 2 Cardiac Arrest and Resuscitation Emergency Medicine 0 works
  3. 3 Cardiovascular Syncope and Autonomic Disorders Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.8%not open66.2%

World: 28% of research is openly available.

with international co-authors14.7%domestic only85.3%

World: 19% is written across borders.

How has Achillion Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 55% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New Haven

All research institutions in New Haven

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.